Campylobacter jejuni: Difference between revisions

 
(One intermediate revision by one other user not shown)
Line 4: Line 4:
*Caused by oral-fecal transmission
*Caused by oral-fecal transmission
*Associated with [[Guillain-Barre syndrome]] and [[Reactive arthritis|Reiter syndrome]]
*Associated with [[Guillain-Barre syndrome]] and [[Reactive arthritis|Reiter syndrome]]
*Incubation period of about 2-5 days, with duration of illness around 2-10 days<ref>U.S. Dept of Health and Human Services. Campylobacter. https://www.foodsafety.gov/poisoning/causes/bacteriaviruses/campylobacter/index.html</ref>


==Clinical Features==
==Clinical Features==
Line 34: Line 35:


==Evaluation==
==Evaluation==
*Initiate work up in patients:
''Not every patient with fever and diarrhea requires work-up - use clinical judgement''
**Appearing toxic
 
**Febrile
*Consider work-up for patient with:
**Diarrheal illness lasting >3 days
**Fever
**Toxic appearance
**Diarrhea lasting >3 days
**Blood or pus in stool
**Blood or pus in stool
**Immunocompromised patients with presumed infectious diarrhea
**Immunocompromised patients with presumed infectious diarrhea
*Bacterial stool culture
*Bacterial stool culture
**N.B. - In many labs, stool culture tests for [[Salmonella]], [[Shigella]], and [[Campylobacter]]
*Stool ova and parasites if concern for parasitic infection
*Stool ova and parasites if concern for parasitic infection
*Consider [[C. difficile]] PCR if patient has risk factors
*Consider [[C. difficile]] PCR if patient has risk factors
*Note- in many labs, stool culture tests for [[Salmonella]], [[Shigella]], and [[Campylobacter]]; discuss with your lab for further testing
*Note- not every patient with fever and diarrhea needs work up, use clinical judgment


==Management<ref>http://www.cdc.gov/nczved/divisions/dfbmd/diseases/campylobacter/#treat</ref>==
==Management<ref>http://www.cdc.gov/nczved/divisions/dfbmd/diseases/campylobacter/#treat</ref>==
*Fluid resuscitation- oral rehydration therapy preferred  
*Fluid resuscitation - oral rehydration therapy preferred  
*Avoid antimotility agents with bloody diarrhea  
*Avoid antimotility agents with bloody diarrhea  
*Many recover without antimicrobial therapy
*Many recover without antimicrobial therapy
*Antibiotics if severe illness:
*Antibiotics if severe illness:
**[[Macrolides]]
**[[Macrolides]] (e.g. [[Azithromycin]])
***[[Azithromycin]]
**[[Fluroquinolones]] (e.g. [[Ciprofloxacin]])
**[[Fluroquinolones]]
**Note - resistance is becoming prevalent (up to 25% resistance with [[ciprofloxacin]]<ref>CDC. Campylobacter (Campylobacteriosis) - Antibiotic resistance. Last modified October 2, 2017. https://www.cdc.gov/campylobacter/campy-antibiotic-resistance.html</ref>)
***[[Ciprofloxacin]]
*Note - resistance is becoming prevalent
**Especially [[ciprofloxacin]], which is as high as 25% resistance now<ref>CDC. Campylobacter (Campylobacteriosis) - Antibiotic resistance. Last modified October 2, 2017. https://www.cdc.gov/campylobacter/campy-antibiotic-resistance.html</ref>


==Disposition==
==Disposition==
*Home for most patients
*Most patients can be discharged
*Admit for rehydration in those with severe illness/inability to tolerate PO
*Admit for rehydration in those with severe illness/inability to tolerate PO


Line 66: Line 65:


==External Links==
==External Links==


==References==
==References==

Latest revision as of 01:46, 12 October 2018

Background

Clinical Features

  • Acute diarrheal illness (<3 weeks)
  • Severe abdominal pain
  • Fever
  • Bloody/voluminous/purulent stools
  • Systemic illness/symptoms

Differential Diagnosis

Acute diarrhea

Infectious

Noninfectious

Watery Diarrhea

Traveler's Diarrhea

Evaluation

Not every patient with fever and diarrhea requires work-up - use clinical judgement

  • Consider work-up for patient with:
    • Fever
    • Toxic appearance
    • Diarrhea lasting >3 days
    • Blood or pus in stool
    • Immunocompromised patients with presumed infectious diarrhea
  • Bacterial stool culture
  • Stool ova and parasites if concern for parasitic infection
  • Consider C. difficile PCR if patient has risk factors

Management[3]

  • Fluid resuscitation - oral rehydration therapy preferred
  • Avoid antimotility agents with bloody diarrhea
  • Many recover without antimicrobial therapy
  • Antibiotics if severe illness:

Disposition

  • Most patients can be discharged
  • Admit for rehydration in those with severe illness/inability to tolerate PO

See Also

External Links

References

  1. U.S. Dept of Health and Human Services. Campylobacter. https://www.foodsafety.gov/poisoning/causes/bacteriaviruses/campylobacter/index.html
  2. Marx et al. “Cholera and Gastroenteritis caused by Noncholera Vibrio Species”. Rosen’s Emergency Medicine 8th edition vol 1 pg 1245-1246.
  3. http://www.cdc.gov/nczved/divisions/dfbmd/diseases/campylobacter/#treat
  4. CDC. Campylobacter (Campylobacteriosis) - Antibiotic resistance. Last modified October 2, 2017. https://www.cdc.gov/campylobacter/campy-antibiotic-resistance.html